Ameriprise’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.54M Buy
8,406
+3,412
+68% +$1.03M ﹤0.01% 2797
2025
Q1
$1.65M Sell
4,994
-3,674
-42% -$1.22M ﹤0.01% 2976
2024
Q4
$2.67M Sell
8,668
-28,992
-77% -$8.95M ﹤0.01% 2745
2024
Q3
$7.99M Buy
37,660
+36,149
+2,392% +$7.67M ﹤0.01% 1996
2024
Q2
$423K Sell
1,511
-102
-6% -$28.6K ﹤0.01% 3472
2024
Q1
$431K Sell
1,613
-3,466
-68% -$926K ﹤0.01% 3465
2023
Q4
$1.18M Buy
5,079
+16
+0.3% +$3.7K ﹤0.01% 3122
2023
Q3
$739K Sell
5,063
-1,654
-25% -$242K ﹤0.01% 3266
2023
Q2
$1.55M Buy
6,717
+5,406
+412% +$1.25M ﹤0.01% 2994
2023
Q1
$318K Sell
1,311
-120
-8% -$29.1K ﹤0.01% 3594
2022
Q4
$415K Buy
+1,431
New +$415K ﹤0.01% 3472
2020
Q1
Sell
-9,787
Closed -$892K 3691
2019
Q4
$892K Sell
9,787
-1,209
-11% -$110K ﹤0.01% 3105
2019
Q3
$948K Buy
10,996
+4,560
+71% +$393K ﹤0.01% 3036
2019
Q2
$675K Sell
6,436
-805
-11% -$84.4K ﹤0.01% 3215
2019
Q1
$907K Buy
7,241
+85
+1% +$10.6K ﹤0.01% 3073
2018
Q4
$807K Buy
7,156
+2,730
+62% +$308K ﹤0.01% 3016
2018
Q3
$948K Sell
4,426
-3,302
-43% -$707K ﹤0.01% 3098
2018
Q2
$2.16M Sell
7,728
-1,177
-13% -$329K ﹤0.01% 2700
2018
Q1
$1.04M Sell
8,905
-11,363
-56% -$1.33M ﹤0.01% 2952
2017
Q4
$1.86M Buy
+20,268
New +$1.86M ﹤0.01% 2682
2014
Q4
Sell
-11
Closed -$1K 4115
2014
Q3
$1K Sell
11
-3
-21% -$273 ﹤0.01% 5514
2014
Q2
$2K Buy
14
+3
+27% +$429 ﹤0.01% 5191
2014
Q1
$2K Hold
11
﹤0.01% 5037
2013
Q4
$2K Sell
11
-75
-87% -$13.6K ﹤0.01% 4870
2013
Q3
$19K Hold
86
﹤0.01% 4447
2013
Q2
$15K Buy
+86
New +$15K ﹤0.01% 4476